Samlyn Capital logo

Samlyn Capital

North America, New York, United States, New York

Description

Samlyn Capital operates as an investment management company.

Investor Profile

Samlyn Capital has backed more than 7 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Chemical Engineering, Recycling.

Stage Focus

  • Post Ipo Equity (86%)
  • Series B (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Chemical Engineering
  • Recycling
  • Waste Management
  • Pharmaceutical
  • Health Care
  • Biopharma
  • Health Diagnostics
  • Therapeutics
  • Commercial
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Samlyn Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
BP
North America, California, United States, San Francisco
Co-Investments: 1
Sylebra Capital
North America, California, United States, Palo Alto
Co-Investments: 3
Altamont Pharmaceutical Holdings
North America, California, United States, San Jose
Co-Investments: 1
Blue Owl
North America, New York, United States, New York
Co-Investments: 1
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 1
DC
North America, Illinois, United States, Chicago
Co-Investments: 1
PC
North America, New York, United States, New York
Co-Investments: 1
Point72
North America, Connecticut, United States, Stamford
Co-Investments: 1
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Samlyn Capital often collaborate with?

RA
North America, United States
Shared Deals: 1

What are some of recent deals done by Samlyn Capital?

PureCycle Technologies

Jacksonville, Florida, United States

PureCycle Technologies offers the only recycled polypropylene with properties equal to virgin polymer.

Chemical EngineeringRecyclingWaste Management
Post Ipo EquityJun 17, 2025
Amount Raised: $300,000,000
PureCycle Technologies

Ironton, Ohio, United States

PureCycle Technologies offers the only recycled polypropylene with properties equal to virgin polymer.

Chemical EngineeringRecyclingWaste Management
Post Ipo EquityFeb 5, 2025
Amount Raised: $33,000,000
Celcuity

Hamel, Minnesota, United States

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Post Ipo EquityMay 30, 2024
Amount Raised: $60,000,000
Corvus Pharmaceuticals

Burlingame, California, United States

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityMay 2, 2024
Amount Raised: $30,600,000
Eliem Therapeutics

Redmond, Washington, United States

Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Series BMay 24, 2021
Amount Raised: $60,000,000
PureCycle Technologies

Ironton, Ohio, United States

PureCycle Technologies offers the only recycled polypropylene with properties equal to virgin polymer.

Chemical EngineeringRecyclingWaste Management
Post Ipo EquityMar 18, 2021
Amount Raised: $250,000,000
Applied Minerals

New York, New York, United States

Applied Minerals produces halloysite clay with commercially consistent product grades.

CommercialManufacturingMineral
Post Ipo EquityJun 27, 2011
Amount Raised: $12,000,000